APA (7th ed.) Citation

Danese, S., Sandborn, W. J., Reinisch, W., Hébuterne, X., Kłopocka, M., Tarabar, D., . . . Vermeire, S. (2019). 772 Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II. The American journal of gastroenterology, 114(1), S448-S449. https://doi.org/10.14309/01.ajg.0000592624.44779.ee

Chicago Style (17th ed.) Citation

Danese, Silvio, et al. "772 Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II." The American Journal of Gastroenterology 114, no. 1 (2019): S448-S449. https://doi.org/10.14309/01.ajg.0000592624.44779.ee.

MLA (9th ed.) Citation

Danese, Silvio, et al. "772 Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II." The American Journal of Gastroenterology, vol. 114, no. 1, 2019, pp. S448-S449, https://doi.org/10.14309/01.ajg.0000592624.44779.ee.

Warning: These citations may not always be 100% accurate.